Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm | U.S.
Louis Milione had retired from the DEA this summer for a second time amid reporting by The Associated Press on potential conflicts caused by his prior consulting for the pharmaceutical industry